European Dravet Syndrome Conference 2027

DEADLINES:
Please, take into account the following important dates:

• Abstract Submission Deadline: Sunday 20 December 2026 at 23:59 CET.
• Email notification of selected speakers & posters: 18 January 2027.
• Reception of final presentation deadline: 2 March 2027 at 23:59 CET.
• Conference Date: 11 and 12 March 2027.

ABSTRACT SUBMISSION GUIDELINES
Abstracts may be selected for poster and/or short (15 min) or flash (10 min) oral presentations. Abstracts should highlight original innovative research on Dravet syndrome, with a special focus on advanced therapy medicinal products (ATMPs). If different abstract and presenting author, more than one abstract can be submitted per institution.

Abstracts will be evaluated by members of the European Dravet Syndrome Advanced Therapies Working Group (EDSAT WG). The EDSAT WG is an alliance formed by leading European scientists in the field of ATMPs for Dravet syndrome and related disorders.

For confidentiality reasons, only the title, authors and affiliations will be published in the online booklet. Full abstracts will only be published in the printed booklet that attendees will receive as part of the conference bag.

AUTHORS AND FORMAT

• Authors should indicate their presentation preference: oral and/or poster presentation. The Scientific Committee reserves the right to decide on the final presentation type.
• Abstracts with multiple authors can only be submitted once, by the presenting author.
• The presenting author assumes full responsibility for the contents of the abstract and confirms that all other authors consent to the submission of the abstract.
• All abstracts must be submitted and presented in English.
• Abstracts must have the following structure: Introduction, Methodology, Results, Conclusions, and Acknowledgement/Funding, if applicable.
• Abbreviations should be defined the first time they appear in the text, before being used as an abbreviation only. Please, do not define or use abbreviations in the title.
• The abstract’s title can contain a maximum of 100 characters.
• Abstracts should have between 1250 and 1500 characters. Title, authors’ names and affiliations are not included in this limit.
• Tables, figures, or other graphics are not allowed during abstract submission.
• Authors affiliations should be written correctly, using capital letters, and avoiding abbreviations.

EVALUATION
Special consideration will be given to:

• Clarity in the exposition of the different sections.
• Innovative potential.
• Scientific impact and social relevance.
• Soundness of the applied methodology.
• Consistency between the obtained results and the proposed conclusions.

Selected speakers will receive all information regarding time and format of their presentations in a separate e-mail after evaluation.

If you face any problems during the submission process, contact us directly at research@dravetfoundation.eu.